🔗 Permalink

Inventor profile of:

Anders JARSTAD

City:

Uppsala

Country:

Sweden

Published Applications:

Last publication date:

2026-02-26

Top Assignees for applications by Anders JARSTAD

The entities that hold a legal rights for patent applications filed by inventor JARSTAD Anders:

Ipsen Biopharm Limited 6 Wrexham, United Kingdom
Affibody AB 1 So1na, Sweden
Galderma Holding SA 1 Zug, Switzerland
AFFIBODY AB 1 Solna, Sweden

Recent patent applications by JARSTAD Anders

Anders JARSTAD from Uppsala, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26

US20260055389A1

Chemistry; metallurgy

METHOD OF PURIFYING BOTULINUM TOXIN

#2 | 2025-08-14

US20250255943A1

Human necessities

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

#3 | 2024-02-15

US20240050539A1

Human necessities

Liquid neurotoxin formulation stabilized with tryptophan or tyrosine

#4 | 2023-06-22

US20230190892A9

Human necessities

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

#5 | 2023-06-15

US20230181702A1

Human necessities

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

#6 | 2023-02-02

US20230029456A1

Chemistry; metallurgy

METHOD OF PURIFYING BOTUFINUM TOXIN

#7 | 2022-11-10

US20220356440A1

Chemistry; metallurgy

METHOD OF PRODUCING BOTULINUM TOXIN

#8 | 2022-05-26

US20220160844A1

Human necessities

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

#9 | 2021-10-28

US20210330765A1

Human necessities

LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE

#10 | 2019-06-20

US20190183988A1

Human necessities

NEUROTOXIN FORMULATION

#11 | 2011-06-16

US20110144302A1

Chemistry; metallurgy

Polypeptide

#12 | 2010-11-18

US20100292434A1

Chemistry; metallurgy

IGF-1R binding polypeptides and their use

InventorID:

2532727 ⎘